Company intelligence / Profile preview

ViroMedica Pacific

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

ViroMedica Pacific was a biotechnology company focused on the development of oncolytic virus therapies for the treatment of various forms of cancer. The company aimed to leverage engineered viruses to selectively target and destroy tumor cells while stimulating a systemic anti-tumor immune response. Despite its early-stage research efforts in the field of gene therapy and virotherapy, the company is no longer active. Its operations were primarily centered on advancing preclinical candidates toward clinical evaluation.

Therapeutic areas: Oncology
Modalities: Oncolytic virus therapyGene therapy
Industry: Biotech

Beyond the preview

Go deeper on ViroMedica Pacific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ViroMedica Pacific.

Explore the full profile